Your cells depend on the SMC1A gene when they need to keep chromosomes organized during cell division and support normal development. Pathogenic variants can disrupt brain development and other body systems. Depending on the variant, this may lead to developmental delay, seizures, learning difficulties, or features of Cornelia de Lange syndrome. Genetic testing can help show whether a change in the SMC1A gene explains these findings.
What is a gene?
Within your DNA, a gene is a stretch that carries instructions your cells use to make molecules or to regulate processes in the body. Some genes provide the directions for making proteins, the parts of cells that do the work. Other genes mainly control when certain processes happen, where they happen, and how strongly they run. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. To explore this topic in more detail, you can learn more in the LearnHub.
Overview
SMC1AGene function
What if the gene works
The SMC1A gene helps package and organize DNA. Its protein is part of a cell team that keeps chromosomes paired correctly during cell division and supports DNA repair and normal control of gene activity.
Risk
What if the gene does not work
Variants in the SMC1A gene can affect growth and brain development, often causing a Cornelia de Lange spectrum condition with developmental delay and distinctive features. Milder or more severe variants may change symptom timing and severity, and some cause epilepsy.
Treatment
What does that mean for your treatment
No SMC1A-specific treatment or drug choice is currently established in clinical guidelines. Care is based on the person’s symptoms, such as developmental, neurologic, or seizure management, rather than the SMC1A variant itself. The SMC1A gene is also being studied in cancer research as a possible biomarker and drug target, but this has not led to routine treatment decisions.
Conditions associated with SMC1A
Gene function
What if the gene works
Inside your cells, the SMC1A gene helps manage DNA in a neat, controlled way. It makes one part of a protein team called cohesin (a group that organizes DNA and holds copied chromosomes together). These jobs support normal cell division and steady gene activity.
The SMC1A gene helps hold copied chromosomes together after DNA is duplicated. This gives cells time to line them up correctly before they separate during cell division.
Its protein helps fold long DNA strands into loops and keep chromosomes neatly arranged. This is part of how the SMC1A gene helps chromosomes stay organized so cells can use the right DNA at the right time.
By shaping DNA loops, the SMC1A gene helps distant control switches reach the genes they regulate. This supports normal patterns of gene activity as cells grow, divide, and specialize.
It also supports DNA repair after everyday cell stress or accidental damage. It helps keep DNA stable while other repair proteins correct the problem.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, including variation in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply reflect natural genetic variation. Sometimes, however, a variant changes how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SMC1A gene can change how the protein folds, how stable it is, or how well it joins the cohesin complex that organizes chromosomes. Milder variants may leave some activity in place, while more severe truncating or splice variants can sharply reduce protein production or disrupt key protein interactions. This range helps explain how variants in the SMC1A gene affect protein function and why some people develop earlier or more marked features than others.
How variants are linked to conditions
Pathogenic variants in the SMC1A gene can cause Cornelia de Lange syndrome, often with growth differences, developmental delay, and recognizable facial features. Other variants cause developmental and epileptic encephalopathy, a childhood epilepsy that also affects development, with seizures starting early in life. SMC1A gene variants linked to Cornelia de Lange syndrome and epilepsy can lead to different patterns of symptoms from one person to another.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely present in the general population. Most do not directly affect health and instead reflect normal human variation. For many genes, having a variant associated with a condition suggests a possible link rather than a definitive diagnosis, particularly when several genes and environmental factors also play a role. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For SMC1A, risk is mainly shaped by whether a disease-causing gene change is present, often as a new change in the child or sometimes inherited in a family. Sex and the exact gene change can also affect how likely symptoms are and how severe they may be. There is not enough evidence to say that lifestyle changes lower the risk tied to SMC1A.
Inheritance of SMC1A variants
Variants in the SMC1A gene are usually inherited in an X linked dominant pattern. A parent carrying the variant can pass it to any child, but the effects often differ between females and males because females have two X chromosomes and males have one. In some SMC1A related conditions, many affected people have a new (de novo) variant that was not inherited from either parent. This SMC1A inheritance pattern helps explain why symptoms and family history can vary widely.
What does my SMC1A result mean for my family?
A disease-causing change in the SMC1A gene usually has an X-linked pattern, so close relatives on the same side of the family may also carry the change and may want to discuss family testing. The effect can vary widely, even within one family, so some relatives may have milder or different features. Some SMC1A changes happen for the first time in one person, which means a parent may not carry it.
Genetic information
Genetic testing
How you find out about variants
Finding out about variants in the SMC1A gene usually involves SMC1A genetic testing using a blood, saliva, or cheek swab sample. A lab reads the gene’s DNA code to look for variants and may report whether a finding helps confirm a diagnosis, is uncertain, or is not linked to disease.
When should I consider getting a genetic test?
Genetic testing for the SMC1A gene may be considered when a child has signs such as developmental delay, epilepsy, unusual facial features, or growth and body differences that suggest a condition linked to this gene. It can also help clarify a diagnosis when there is a family history of a similar condition.
A genetic result is only one part of your health story
Genetic test results can provide useful insight, but the amount they reveal varies with the condition and the kind of variant involved. How the body works over time is also shaped by factors such as lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best understood alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, these results can also help explain individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, seems less helpful for another, or causes more side effects in someone else. Small differences in how the body breaks down, moves, or responds to a drug are common, and they can influence both benefit and sensitivity.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes affect their response to medicines. It studies gene drug patterns to help explain why the same treatment can work differently in different people. With many medications, genes can influence both how much effect a drug has and how the body handles it. Understanding this can support treatment choices that are more informed and more tailored to the individual. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the SMC1A gene
When should I seek medical advice?
There isn't yet a broadly confirmed role for this gene in guiding medication choices. Questions about side effects, new symptoms, or how your medicines fit with your overall health are best discussed with your doctor.
History
The SMC1A gene entered medical genetics through basic research on how chromosomes are organized during cell division, with human studies taking shape in the late 1990s and early 2000s. Building on this early work, scientists uncovered more about the gene. A major turning point came when variants in the SMC1A gene were linked to Cornelia de Lange syndrome, helping connect chromosome research with day to day clinical care. Later, more disruptive variants were recognized in people with developmental and epilepsy related conditions, which broadened how doctors understood the gene’s role in health. Over time, this history made the SMC1A gene an important part of both chromosome biology and rare disease diagnosis.